Cas:511295-09-3 5-Chloro-4-methoxy-2-methylphenylboronic acid manufacturer & supplier

We serve Chemical Name:5-Chloro-4-methoxy-2-methylphenylboronic acid CAS:511295-09-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-Chloro-4-methoxy-2-methylphenylboronic acid

Chemical Name:5-Chloro-4-methoxy-2-methylphenylboronic acid
CAS.NO:511295-09-3
Synonyms:(5-chloro-4-methoxy-2-methylphenyl)boronic acid
Molecular Formula:C8H10BClO3
Molecular Weight:200.42700
HS Code:2931900090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:49.69000
Exact Mass:200.04100
LogP:0.33680

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (5-chloro-4-methoxy-2-methylphenyl)boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(5-chloro-4-methoxy-2-methylphenyl)boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(5-chloro-4-methoxy-2-methylphenyl)boronic acid Use and application,(5-chloro-4-methoxy-2-methylphenyl)boronic acid technical grade,usp/ep/jp grade.


Related News: This scheme has a total outlay of Rs. 6,940 crore for the entire period. The applications under four different target segments were invited on November 30, 2020. Of the 215 applications, 36 products across the 4 target segments were granted. [([9]aneS3)Ru(1,2-dicyanobenzene)3])(3+) manufacturers UK-headquartered Verona announced at the beginning of the year that it had completed enrolment in a pilot study evaluating the efficacy of ensifentrine delivered via pressurised metered-dose inhaler (pMDI) formulation in patients hospitalised with COVID-19. 9H-Purin-6-amine, N-cyclopropyl-9-propyl- suppliers Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. 4-(2-Chlorophenyl)-2-methyl-6-(4-piperidinobutoxy)pyrimidine hydrochloride vendor & factory.